Company / Total Debt
ACCENDRA HEALTH INC/VA/ Total Debt History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$1.0B
FY2020
5-year range
-
FY2016-FY2020
Trend
-34.2%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $1.7B to $1.0B over the past 2 years.
Based on SEC 10-K filings.
$1.0B in FY2020 with a 3-year CAGR of +3.8%.
Improved from $1.7B to $1.0B over the past 2 years.
Total Debt over time
Growth rates
- 3-Year CAGR
- +3.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +3.8%, indicating consistent growth.
- In FY2020, total debt decreased 34.2% year-over-year.
- Peak total debt was recorded in FY2018.
- Lowest total debt in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $1.0B | -34.2% |
| FY2019 | $1.6B | -7.0% |
| FY2018 | $1.7B | +82.8% |
| FY2017 | $917.4M | +61.1% |
| FY2016 | $569.4M | -0.7% |
As of FY2020 · SEC 10-K · Updated Jun 24, 2026